ANIX 最新10-Q变化
将 ANIX 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-06-10 与上一份 10-Q · 2026-03-09
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +9 | −2 | ~8 | 17 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~1 | 1 |
| 法律诉讼 | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 风险因素 | 公司称无重大变化(指向 10-K) | — | — | — | — |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):市场风险(第3项)、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-06-10
Research and development expenses decreased by approximately $64,000 to approximately $1,258,000 in the three months ended April 30, 2026, from approximately $1,322,000 in the three months ended April 30, 2025. The decrease in research and development expenses was primarily due to a decrease in empl…
General and administrative expenses decreased by approximately $292,000 to approximately $1,389,000 in the three months ended April 30, 2026, from approximately $1,681,000 in the three months ended April 30, 2025. The decrease in general and administrative expenses was primarily due to a decrease in…
Six months ended April 30, 2026 compared with six months ended April 30, 2025
We had no revenue during the six-month periods ended April 30, 2026 and 2025.
During the six months ended April 30, 2026, research and development expenses related to the development of our cancer vaccines and CAR-T therapeutics consisted of approximately $1,485,000 and $875,000, respectively. During the six months ended April 30, 2025 research and development expenses relate…
相对上期删除的文字 · 来源:10-Q · 2026-03-09
Research and development expenses decreased by approximately $450,000 to approximately $1,102,000 in the three months ended January 31, 2026, from approximately $1,552,000 in the three months ended January 31, 2025. The decrease in research and development expenses was primarily due to a decrease in…
General and administrative expenses decreased by approximately $220,000 to approximately $1,614,000 in the three months ended January 31, 2026, from approximately $1,834,000 in the three months ended January 31, 2025. The decrease in general and administrative expenses was primarily due to a decreas…
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议